{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:15Z","timestamp":1792686255328,"version":"4.5.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To address the overestimation of levothyroxine (L-T4) doses in conventional weight-based regimens for individuals who are overweight and obese, this study aimed to identify the most predictive body weight metrics and establish an optimized dosing model for accurate thyroid-stimulating hormone (TSH) suppression following total thyroidectomy in differentiated thyroid carcinoma (DTC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 385 patients with DTC treated at our institution between October 2019 and December 2024. Patients were stratified by TSH targets (A1: &amp;lt;0.1 mIU\/L; A2: 0.1\u20130.5 mIU\/L; A3: 0.5\u20132.0 mIU\/L) and body mass index (BMI) according to Chinese criteria (normal: &amp;lt;24 kg\/m\u00b2; overweight: 24\u201327.9 kg\/m\u00b2; obesity: \u226528 kg\/m\u00b2). Linear regression analysis was used to analyze correlations between the final stable L-T4 dose and weight metrics, including total body weight, adjusted body weight, lean body weight, ideal body weight, and body surface area, followed by model validation. Model performance was internally validated using a hold-out method. Efficacy was estimated as the accuracy of the model-predicted dose compared with the actual dose required when a patient first achieved their TSH target within the first postoperative year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The baseline characteristics showed no significant intergroup differences (P&amp;gt;0.05). Postoperative TSH levels varied significantly according to BMI (P&amp;lt;0.05). Patients with higher BMI required higher total L-T4 doses (\u00b5g\/d) (P&amp;lt;0.001) but lower weight-adjusted doses (\u00b5g\/kg\/d) (P&amp;lt;0.001). Adjusted body weight best predicted L-T4 dose for patients with BMI \u2264 23.9 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , while lean body weight was optimal for those with BMI\u226524.0 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . The new model achieved a significantly higher rate of accurate initial dose prediction compared with that via empirical dosing (68.0% vs. 30.2%, P&amp;lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The BMI-stratified L-T4 dosing formula based on optimized body weight metrics demonstrated improved accuracy, expediting TSH suppression and reducing adverse events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1727681","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:45:51Z","timestamp":1765953951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Levothyroxine dose prediction post-thyroidectomy for differentiated thyroid carcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Li","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujie","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0484","article-title":"Thyroid cancer: risk-stratified management and individualized therapy","volume":"22","author":"Raue","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262402","article-title":"Management of differentiated thyroid cancer: the standard of care","volume":"63","author":"Avram","year":"2022","journal-title":"J Nucl Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03408-5","article-title":"Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study","volume":"82","author":"Hassanipour","year":"2023","journal-title":"Endocrine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0311","article-title":"Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer","volume":"20","author":"Biondi","year":"2010","journal-title":"Thyroid"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.186","article-title":"Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): a prospective study","volume":"3","author":"Fallahi","year":"2018","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4158\/EP09257.OR","article-title":"Sex and age differences in levothyroxine dosage requirement","volume":"16","author":"Jonklaas","year":"2010","journal-title":"Endocr Pract"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0125","article-title":"Patient-tailored levothyroxine dosage with pharmacokinetic\/pharmacodynamic modeling: A novel approach after total thyroidectomy","volume":"31","author":"Brun","year":"2021","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2012.12.002","article-title":"Using body mass index to predict optimal thyroid dosing after thyroidectomy","volume":"216","author":"Ojomo","year":"2013","journal-title":"J Am Coll Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.758043","article-title":"Levothyroxine treatment and the risk of cardiac arrhythmias\u2014focus on the patient submitted to thyroid surgery","volume":"12","author":"Gluvic","year":"2021","journal-title":"Front Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa430","article-title":"Individualized therapy for hypothyroidism: is T4 enough for everyone","volume":"105","author":"Ettleson","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.626268","article-title":"Levothyroxine therapy in Thyrodectomized patients","volume":"11","author":"Miccoli","year":"2020","journal-title":"Front Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.14336\/AD.2020.0919","article-title":"Adiponectin and thyroid cancer: insight into the association between adiponectin and obesity","volume":"12","author":"Zhou","year":"2021","journal-title":"Aging Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14735","article-title":"Effect of lipophilicity on drug distribution and elimination: influence of obesity","volume":"87","author":"Bruno","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.959276","article-title":"Inflammasome activation as a link between obesity and thyroid disorders: implications for an integrated clinical management","volume":"13","author":"Le Moli","year":"2022","journal-title":"Front Endocrinol (Laus)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120690","article-title":"Central sensitivity to thyroid hormone indices and glucose metabolism disorders","volume":"579","author":"Zhang","year":"2025","journal-title":"Clin Chim Acta"},{"key":"B19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4103\/ijem.IJEM_502_16","article-title":"Does one size fit everyone? Replacement dose of levothyroxine in long-standing primary hypothyroidismin adults","volume":"21","author":"Singh","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-021-09691-9","article-title":"Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults","volume":"23","author":"Caron","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"B21","volume-title":"Criteria of weight for adults: WS\/T 428-2013","year":"2013"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-022-00376-9","article-title":"Seeking optimization of LT4 treatment in patients with differentiated thyroid cancer","volume":"21","author":"Stramazzo","year":"2022","journal-title":"Horm (Ath)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2019.06.025","article-title":"Optimizing levothyroxine dose adjustment after thyroidectomy with a decision tree","volume":"244","author":"Chen","year":"2019","journal-title":"J Surg Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12325-019-01078-2","article-title":"Levothyroxine dose adjustment to optimise therapy throughout a Patient\u2019s lifetime","volume":"36","author":"Duntas","year":"2019","journal-title":"Adv Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2018.04.097","article-title":"The optimal dosing scheme for levothyroxine after thyroidectomy: a comprehensive comparison and evaluation","volume":"165","author":"Zaborek","year":"2019","journal-title":"Surgery"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1425101","article-title":"A predictive model for L-T4 dose in postoperative DTC after RAI therapy and its clinical validation in two institutions","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0251","article-title":"Evaluation of thyroid hormone replacement dosing in overweight and obese patients after a thyroidectomy","volume":"29","author":"Papoian","year":"2019","journal-title":"Thyroid"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1306","article-title":"Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases","volume":"90","author":"Santini","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-0345-3","article-title":"Prediction of LT4 replacement dose to achieve euthyroidism in subjects undergoing total thyroidectomy for benign thyroid disorders","volume":"34","author":"Sukumar","year":"2010","journal-title":"World J Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/srep27966","article-title":"Body surface area formulae: an alarming ambiguity","volume":"6","author":"Redlarski","year":"2016","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3760\/cma.j.cn311282-20221023-00589","article-title":"Clinical guidelines for thyroid nodules and differentiated thyroid carcinoma","volume":"39","year":"2023","journal-title":"Chin J Endocrinol Metab"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-19425-7","volume-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"Harrell","year":"2015"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.12.014","article-title":"The number of subjects per variable required in linear regression analyses","volume":"68","author":"Austin","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2020.100547","article-title":"Beyond recent BMI: BMI exposure metrics and their relationship to health","volume":"11","author":"Ng","year":"2020","journal-title":"SSM Popul Health"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2023.03.027","article-title":"Analgesic efficacy of systemic lidocaine using lean body mass based dosing regime versus placebo in bariatric surgery: a prospective, randomised, double-blind, placebo-controlled, single-centre study","volume":"131","author":"Yurttas","year":"2023","journal-title":"Br J Anaesth"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0033","article-title":"Computer-assisted levothyroxine dose selection for the treatment of postoperative hypothyroidism","volume":"33","author":"Barrio","year":"2023","journal-title":"Thyroid"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2021.03.016","article-title":"Comparison of dosing schemes for thyroid hormone replacement therapy after thyroidectomy","volume":"264","author":"Valenzuela","year":"2021","journal-title":"J Surg Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4158\/EP15836.OR","article-title":"Levothyroxine replacement in obese hypothyroid females after total thyroidectomy","volume":"22","author":"Glymph","year":"2016","journal-title":"Endocr Pract"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/lary.23186","article-title":"Levothyroxine dose following thyroidectomy is affected by more than just body weight","volume":"122","author":"Baehr","year":"2012","journal-title":"Laryngoscope"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12321","article-title":"Adiposity and risk of thyroid cancer: a systematic review and meta-analysis","volume":"16","author":"Schmid","year":"2015","journal-title":"Obes Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e58430","DOI":"10.7759\/cureus.58430","article-title":"Optimizing thyroxine dosage after total thyroidectomy: understanding the factors at play","volume":"16","author":"Dawn Paul E","year":"2024","journal-title":"Cureus"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2021.100264","article-title":"Appropriate dose of levothyroxine replacement therapy for hypothyroid obese patients","volume":"25","author":"Ratanapornsompong","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.15605\/jafes.037.01.19","article-title":"Profile of levothyroxine replacement therapy in Graves\u2019 disease patients with hypothyroidism post-radioactive iodine ablation: focus on different weight-based regimens","volume":"37","author":"Mathiphanit","year":"2022","journal-title":"J ASEAN Fed Endocr Soc"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0111","article-title":"A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease","volume":"24","author":"Di Donna","year":"2014","journal-title":"Thyroid"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2024.100335","article-title":"Are lean body mass and fat-free mass the same or different body components? A critical perspective","volume":"15","author":"Heymsfield","year":"2024","journal-title":"Adv Nutr"},{"key":"B46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/thy.2022.0161","article-title":"Thyroid hormone metabolism: A historical perspective","volume":"33","author":"Galton","year":"2023","journal-title":"Thyroid"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.8.8754756","article-title":"Molecular biological and biochemical characterization of the human type 2 selenodeiodinase","volume":"137","author":"Salvatore","year":"1996","journal-title":"Endocrinology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1089\/thy.2015.0473","article-title":"Weight loss and variation of levothyroxine requirements in hypothyroid obese patients after bariatric surgery","volume":"26","author":"Fierabracci","year":"2016","journal-title":"Thyroid"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1422464","article-title":"Gender, FT4 levels, T stage, and BMI as predictors of TSH levels in thyroid cancer patients","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Endocrinol (Laus)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/bjs.5157","article-title":"Optimization of thyroxine replacement therapy after total or near-total thyroidectomy for benign thyroid disease","volume":"93","author":"Olubowale","year":"2006","journal-title":"Br J Surg"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2015.10.005","article-title":"Prospective intervention of a novel levothyroxine dosing protocol based on body mass index after thyroidectomy","volume":"222","author":"Elfenbein","year":"2016","journal-title":"J Am Coll Surg"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1727681\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:45:55Z","timestamp":1765953955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1727681\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":51,"alternative-id":["10.3389\/fendo.2025.1727681"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1727681","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"article-number":"1727681"}}